Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation
Movement Disorders Clinical Practice · 2025
DOI: 10.1002/mdc3.14294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2025. Verfasst von Pawel Jarski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Leucencephalopathy (LE) is often detected on magnetic resonance imaging in elderly patients. These white matter lesions may interfere with lead trajectories for deep brain stimulation (DBS) in patients with Parkinson's disease (PD) and are associated with complications after DBS surgery.
Objective
This study was conducted to assess the incidence of LE in PD patients and to evaluate correlations with complications after DBS surgery.
Methods
A consecutive cohort of PD patients who underwent DBS surgery in the subthalamic nucleus (STN‐DBS) was retrospectively analyzed. The presence and extent of LE were quantified using the Fazekas scale. Postoperative complications were extracted from the medical records. DBS efficacy was calculated using the side‐specific motor symptom ratio (Unified Parkinson's Disease Rating Scale, Part III, postoperative stimulation ON/medication off divided by preoperative medication off ) at 1‐year follow‐up.
Results
A total of 135 PD patients were included in the study. LE was detected in 35.6% (48/135) of the patients. In 87.7% (57/65), LE was mild, in 10.7% (7/65) moderate, and in 1.6% (1/65) severe. A higher incidence of mild to moderate LE did not correlate with postoperative hemorrhage or postoperative infection. There was no correlation of LE with stimulation efficacy ( r = −0.05, P = 0.69) or with surgical index ( r = −0.10, P = 0.35).
Conclusions
Neither was the presence of mild to moderate LE associated with an increased risk for surgical complications, nor did it negatively impact the long‐term improvement in motor function after DBS surgery in PD patients. Therefore, mild to moderate LE should not be considered a contraindication for DBS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany.
- Paracelsus Elena Clinic, Kassel, Germany.
- Department of Neurosurgery, Westpfalz-Klinikum, Kaiserslautern, Germany.
- Department of Neurology, University Medical Center, Göttingen, Germany.
- Department of Neurosurgery, University Hospital Augsburg, Augsburg, Germany.
ORCID-Profile: Brit Mollenhauer
Zitieren
APA
Jarski, P., Gasimov, T., Dragaescu, C., Sixel-Döring, F., von Eckardstein, K., Mollenhauer, B., Trenkwalder, C., Mielke, D., Rohde, V., & Malinova, V. (2025). Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14294
Vancouver
Jarski P, Gasimov T, Dragaescu C, Sixel-Döring F, von Eckardstein K, Mollenhauer B, et al. Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation. Movement Disorders Clinical Practice. 2025. doi:10.1002/mdc3.14294
BibTeX
@article{Jarski2025,
author = {Jarski, Pawel and Gasimov, Turab and Dragaescu, Cristina and Sixel-Döring, Friederike and von Eckardstein, Kajetan and Mollenhauer, Brit and Trenkwalder, Claudia and Mielke, Dorothee and Rohde, Veit and Malinova, Vesna},
title = {Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation},
journal = {Movement Disorders Clinical Practice},
year = {2025},
doi = {10.1002/mdc3.14294}
}
EUVIMED